Publication Information

{'id': 'https://openalex.org/W2558754297', 'doi': 'https://doi.org/10.18632/oncotarget.13769', 'title': 'Axitinib induces senescence-associated cell death and necrosis in glioma cell lines: The proteasome inhibitor, bortezomib, potentiates axitinib-induced cytotoxicity in a p21(Waf/Cip1) dependent manner', 'display_name': 'Axitinib induces senescence-associated cell death and necrosis in glioma cell lines: The proteasome inhibitor, bortezomib, potentiates axitinib-induced cytotoxicity in a p21(Waf/Cip1) dependent manner', 'publication_year': 2016, 'publication_date': '2016-12-01', 'ids': {'openalex': 'https://openalex.org/W2558754297', 'doi': 'https://doi.org/10.18632/oncotarget.13769', 'mag': '2558754297', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/27926485', 'pmcid': 'https://www.ncbi.nlm.nih.gov/pmc/articles/5356889'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.18632/oncotarget.13769', 'pdf_url': 'http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=13769&path%5B%5D=43776', 'source': {'id': 'https://openalex.org/S126644158', 'display_name': 'Oncotarget', 'issn_l': '1949-2553', 'issn': ['1949-2553'], 'is_oa': True, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310316297', 'host_organization_name': 'Impact Journals LLC', 'host_organization_lineage': ['https://openalex.org/P4310316297'], 'host_organization_lineage_names': ['Impact Journals LLC'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': True, 'oa_status': 'gold', 'oa_url': 'http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=13769&path%5B%5D=43776', 'any_repository_has_fulltext': True}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5086612949', 'display_name': 'Maria Beatrice Morelli', 'orcid': 'https://orcid.org/0000-0002-4614-5649'}, 'institutions': [{'id': 'https://openalex.org/I112859197', 'display_name': 'Università di Camerino', 'ror': 'https://ror.org/0005w8d69', 'country_code': 'IT', 'type': 'education', 'lineage': ['https://openalex.org/I112859197']}, {'id': 'https://openalex.org/I861853513', 'display_name': 'Sapienza University of Rome', 'ror': 'https://ror.org/02be6w209', 'country_code': 'IT', 'type': 'education', 'lineage': ['https://openalex.org/I861853513']}], 'countries': ['IT'], 'is_corresponding': False, 'raw_author_name': 'Maria Beatrice Morelli', 'raw_affiliation_strings': ['Department of Molecular Medicine, Sapienza University, Rome, Italy', 'School of Pharmacy, University of Camerino, Camerino, Italy'], 'affiliations': [{'raw_affiliation_string': 'School of Pharmacy, University of Camerino, Camerino, Italy', 'institution_ids': ['https://openalex.org/I112859197']}, {'raw_affiliation_string': 'Department of Molecular Medicine, Sapienza University, Rome, Italy', 'institution_ids': ['https://openalex.org/I861853513']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5032531876', 'display_name': 'Consuelo Amantini', 'orcid': 'https://orcid.org/0000-0001-8711-9941'}, 'institutions': [{'id': 'https://openalex.org/I112859197', 'display_name': 'Università di Camerino', 'ror': 'https://ror.org/0005w8d69', 'country_code': 'IT', 'type': 'education', 'lineage': ['https://openalex.org/I112859197']}], 'countries': ['IT'], 'is_corresponding': False, 'raw_author_name': 'Consuelo Amantini', 'raw_affiliation_strings': ['School of Biosciences and Veterinary Medicine, University of Camerino, Camerino, Italy'], 'affiliations': [{'raw_affiliation_string': 'School of Biosciences and Veterinary Medicine, University of Camerino, Camerino, Italy', 'institution_ids': ['https://openalex.org/I112859197']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5035812888', 'display_name': 'Massimo Nabissi', 'orcid': 'https://orcid.org/0000-0003-0165-1385'}, 'institutions': [{'id': 'https://openalex.org/I112859197', 'display_name': 'Università di Camerino', 'ror': 'https://ror.org/0005w8d69', 'country_code': 'IT', 'type': 'education', 'lineage': ['https://openalex.org/I112859197']}], 'countries': ['IT'], 'is_corresponding': False, 'raw_author_name': 'Massimo Nabissi', 'raw_affiliation_strings': ['School of Pharmacy, University of Camerino, Camerino, Italy'], 'affiliations': [{'raw_affiliation_string': 'School of Pharmacy, University of Camerino, Camerino, Italy', 'institution_ids': ['https://openalex.org/I112859197']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5017662369', 'display_name': 'Claudio Cardinali', 'orcid': 'https://orcid.org/0000-0001-6478-5706'}, 'institutions': [{'id': 'https://openalex.org/I112859197', 'display_name': 'Università di Camerino', 'ror': 'https://ror.org/0005w8d69', 'country_code': 'IT', 'type': 'education', 'lineage': ['https://openalex.org/I112859197']}, {'id': 'https://openalex.org/I861853513', 'display_name': 'Sapienza University of Rome', 'ror': 'https://ror.org/02be6w209', 'country_code': 'IT', 'type': 'education', 'lineage': ['https://openalex.org/I861853513']}], 'countries': ['IT'], 'is_corresponding': False, 'raw_author_name': 'Claudio Cardinali', 'raw_affiliation_strings': ['Department of Molecular Medicine, Sapienza University, Rome, Italy', 'School of Pharmacy, University of Camerino, Camerino, Italy'], 'affiliations': [{'raw_affiliation_string': 'School of Pharmacy, University of Camerino, Camerino, Italy', 'institution_ids': ['https://openalex.org/I112859197']}, {'raw_affiliation_string': 'Department of Molecular Medicine, Sapienza University, Rome, Italy', 'institution_ids': ['https://openalex.org/I861853513']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5021477463', 'display_name': 'Matteo Santoni', 'orcid': 'https://orcid.org/0000-0001-7340-6173'}, 'institutions': [{'id': 'https://openalex.org/I122534668', 'display_name': 'Marche Polytechnic University', 'ror': 'https://ror.org/00x69rs40', 'country_code': 'IT', 'type': 'education', 'lineage': ['https://openalex.org/I122534668']}], 'countries': ['IT'], 'is_corresponding': False, 'raw_author_name': 'Matteo Santoni', 'raw_affiliation_strings': ['Department of Medical Oncology, Polytechnic University of Marche, Ancona, Italy'], 'affiliations': [{'raw_affiliation_string': 'Department of Medical Oncology, Polytechnic University of Marche, Ancona, Italy', 'institution_ids': ['https://openalex.org/I122534668']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5081879325', 'display_name': 'Giovanni Bernardini', 'orcid': 'https://orcid.org/0000-0002-3705-2598'}, 'institutions': [{'id': 'https://openalex.org/I861853513', 'display_name': 'Sapienza University of Rome', 'ror': 'https://ror.org/02be6w209', 'country_code': 'IT', 'type': 'education', 'lineage': ['https://openalex.org/I861853513']}, {'id': 'https://openalex.org/I3018288129', 'display_name': 'Istituto Neurologico Mediterraneo', 'ror': 'https://ror.org/00cpb6264', 'country_code': 'IT', 'type': 'healthcare', 'lineage': ['https://openalex.org/I3018288129', 'https://openalex.org/I4210153126']}], 'countries': ['IT'], 'is_corresponding': False, 'raw_author_name': 'Giovanni Bernardini', 'raw_affiliation_strings': ['Department of Molecular Medicine, Sapienza University, Rome, Italy', 'I.N.M. Neuromed, Pozzilli, Isernia, Italy'], 'affiliations': [{'raw_affiliation_string': 'Department of Molecular Medicine, Sapienza University, Rome, Italy', 'institution_ids': ['https://openalex.org/I861853513']}, {'raw_affiliation_string': 'I.N.M. Neuromed, Pozzilli, Isernia, Italy', 'institution_ids': ['https://openalex.org/I3018288129']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5024871281', 'display_name': 'Angela Santoni', 'orcid': 'https://orcid.org/0000-0003-1206-7731'}, 'institutions': [{'id': 'https://openalex.org/I3018288129', 'display_name': 'Istituto Neurologico Mediterraneo', 'ror': 'https://ror.org/00cpb6264', 'country_code': 'IT', 'type': 'healthcare', 'lineage': ['https://openalex.org/I3018288129', 'https://openalex.org/I4210153126']}, {'id': 'https://openalex.org/I861853513', 'display_name': 'Sapienza University of Rome', 'ror': 'https://ror.org/02be6w209', 'country_code': 'IT', 'type': 'education', 'lineage': ['https://openalex.org/I861853513']}], 'countries': ['IT'], 'is_corresponding': False, 'raw_author_name': 'Angela Santoni', 'raw_affiliation_strings': ['Department of Molecular Medicine, Sapienza University, Rome, Italy', 'I.N.M. Neuromed, Pozzilli, Isernia, Italy'], 'affiliations': [{'raw_affiliation_string': 'I.N.M. Neuromed, Pozzilli, Isernia, Italy', 'institution_ids': ['https://openalex.org/I3018288129']}, {'raw_affiliation_string': 'Department of Molecular Medicine, Sapienza University, Rome, Italy', 'institution_ids': ['https://openalex.org/I861853513']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5079690240', 'display_name': 'Giorgio Santoni', 'orcid': 'https://orcid.org/0000-0003-2757-7064'}, 'institutions': [{'id': 'https://openalex.org/I112859197', 'display_name': 'Università di Camerino', 'ror': 'https://ror.org/0005w8d69', 'country_code': 'IT', 'type': 'education', 'lineage': ['https://openalex.org/I112859197']}], 'countries': ['IT'], 'is_corresponding': True, 'raw_author_name': 'Giorgio Santoni', 'raw_affiliation_strings': ['School of Pharmacy, University of Camerino, Camerino, Italy'], 'affiliations': [{'raw_affiliation_string': 'School of Pharmacy, University of Camerino, Camerino, Italy', 'institution_ids': ['https://openalex.org/I112859197']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 4, 'corresponding_author_ids': ['https://openalex.org/A5079690240'], 'corresponding_institution_ids': ['https://openalex.org/I112859197'], 'apc_list': None, 'apc_paid': None, 'fwci': 1.306, 'has_fulltext': True, 'fulltext_origin': 'pdf', 'cited_by_count': 37, 'citation_normalized_percentile': {'value': 0.833945, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 94, 'max': 95}, 'biblio': {'volume': '8', 'issue': '2', 'first_page': '3380', 'last_page': '3395'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11041', 'display_name': 'Ubiquitin and proteasome pathways', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11041', 'display_name': 'Ubiquitin and proteasome pathways', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T10583', 'display_name': 'Cancer-related Molecular Pathways', 'score': 0.9992, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10294', 'display_name': 'Cell death mechanisms and regulation', 'score': 0.9987, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/axitinib', 'display_name': 'Axitinib', 'score': 0.8408505}, {'id': 'https://openalex.org/keywords/senescence', 'display_name': 'Senescence', 'score': 0.6414491}], 'concepts': [{'id': 'https://openalex.org/C2776539811', 'wikidata': 'https://www.wikidata.org/wiki/Q4830631', 'display_name': 'Axitinib', 'level': 4, 'score': 0.8408505}, {'id': 'https://openalex.org/C2777478702', 'wikidata': 'https://www.wikidata.org/wiki/Q419319', 'display_name': 'Bortezomib', 'level': 3, 'score': 0.8396869}, {'id': 'https://openalex.org/C2778367456', 'wikidata': 'https://www.wikidata.org/wiki/Q7251235', 'display_name': 'Proteasome inhibitor', 'level': 3, 'score': 0.72058123}, {'id': 'https://openalex.org/C109316439', 'wikidata': 'https://www.wikidata.org/wiki/Q246181', 'display_name': 'Cytotoxicity', 'level': 3, 'score': 0.71931356}, {'id': 'https://openalex.org/C522857546', 'wikidata': 'https://www.wikidata.org/wiki/Q2070979', 'display_name': 'Senescence', 'level': 2, 'score': 0.6414491}, {'id': 'https://openalex.org/C31573885', 'wikidata': 'https://www.wikidata.org/wiki/Q304484', 'display_name': 'Programmed cell death', 'level': 3, 'score': 0.5833174}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.5657688}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.5649446}, {'id': 'https://openalex.org/C27740335', 'wikidata': 'https://www.wikidata.org/wiki/Q14878333', 'display_name': 'Proteasome', 'level': 2, 'score': 0.524999}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.5028076}, {'id': 'https://openalex.org/C503630168', 'wikidata': 'https://www.wikidata.org/wiki/Q178069', 'display_name': 'Necrosis', 'level': 2, 'score': 0.43471885}, {'id': 'https://openalex.org/C190283241', 'wikidata': 'https://www.wikidata.org/wiki/Q14599311', 'display_name': 'Apoptosis', 'level': 2, 'score': 0.40187487}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.27849743}, {'id': 'https://openalex.org/C203014093', 'wikidata': 'https://www.wikidata.org/wiki/Q101929', 'display_name': 'Immunology', 'level': 1, 'score': 0.21487218}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.15721744}, {'id': 'https://openalex.org/C2776364478', 'wikidata': 'https://www.wikidata.org/wiki/Q467635', 'display_name': 'Multiple myeloma', 'level': 2, 'score': 0.15690231}, {'id': 'https://openalex.org/C202751555', 'wikidata': 'https://www.wikidata.org/wiki/Q221681', 'display_name': 'In vitro', 'level': 2, 'score': 0.14380354}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.08585885}, {'id': 'https://openalex.org/C2778695046', 'wikidata': 'https://www.wikidata.org/wiki/Q421136', 'display_name': 'Sorafenib', 'level': 3, 'score': 0.0}, {'id': 'https://openalex.org/C2778019345', 'wikidata': 'https://www.wikidata.org/wiki/Q1148337', 'display_name': 'Hepatocellular carcinoma', 'level': 2, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D016922', 'descriptor_name': 'Cellular Senescence', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': True}, {'descriptor_ui': 'D007093', 'descriptor_name': 'Imidazoles', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D007191', 'descriptor_name': 'Indazoles', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D047428', 'descriptor_name': 'Protein Kinase Inhibitors', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D000077784', 'descriptor_name': 'Axitinib', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000069286', 'descriptor_name': 'Bortezomib', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000069286', 'descriptor_name': 'Bortezomib', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D016923', 'descriptor_name': 'Cell Death', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016923', 'descriptor_name': 'Cell Death', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D045744', 'descriptor_name': 'Cell Line, Tumor', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D002470', 'descriptor_name': 'Cell Survival', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D002470', 'descriptor_name': 'Cell Survival', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D002470', 'descriptor_name': 'Cell Survival', 'qualifier_ui': 'Q000235', 'qualifier_name': 'genetics', 'is_major_topic': False}, {'descriptor_ui': 'D016922', 'descriptor_name': 'Cellular Senescence', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016922', 'descriptor_name': 'Cellular Senescence', 'qualifier_ui': 'Q000235', 'qualifier_name': 'genetics', 'is_major_topic': False}, {'descriptor_ui': 'D050759', 'descriptor_name': 'Cyclin-Dependent Kinase Inhibitor p21', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D050759', 'descriptor_name': 'Cyclin-Dependent Kinase Inhibitor p21', 'qualifier_ui': 'Q000235', 'qualifier_name': 'genetics', 'is_major_topic': False}, {'descriptor_ui': 'D050759', 'descriptor_name': 'Cyclin-Dependent Kinase Inhibitor p21', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004249', 'descriptor_name': 'DNA Damage', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004249', 'descriptor_name': 'DNA Damage', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D004305', 'descriptor_name': 'Dose-Response Relationship, Drug', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004357', 'descriptor_name': 'Drug Synergism', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D059565', 'descriptor_name': 'G2 Phase Cell Cycle Checkpoints', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D059565', 'descriptor_name': 'G2 Phase Cell Cycle Checkpoints', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015870', 'descriptor_name': 'Gene Expression', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005910', 'descriptor_name': 'Glioma', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D005910', 'descriptor_name': 'Glioma', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005910', 'descriptor_name': 'Glioma', 'qualifier_ui': 'Q000235', 'qualifier_name': 'genetics', 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007093', 'descriptor_name': 'Imidazoles', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007191', 'descriptor_name': 'Indazoles', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008938', 'descriptor_name': 'Mitosis', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008938', 'descriptor_name': 'Mitosis', 'qualifier_ui': 'Q000235', 'qualifier_name': 'genetics', 'is_major_topic': False}, {'descriptor_ui': 'D008938', 'descriptor_name': 'Mitosis', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D009336', 'descriptor_name': 'Necrosis', 'qualifier_ui': 'Q000235', 'qualifier_name': 'genetics', 'is_major_topic': False}, {'descriptor_ui': 'D009336', 'descriptor_name': 'Necrosis', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D061988', 'descriptor_name': 'Proteasome Inhibitors', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D061988', 'descriptor_name': 'Proteasome Inhibitors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D047428', 'descriptor_name': 'Protein Kinase Inhibitors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D017382', 'descriptor_name': 'Reactive Oxygen Species', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D017382', 'descriptor_name': 'Reactive Oxygen Species', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015398', 'descriptor_name': 'Signal Transduction', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D015398', 'descriptor_name': 'Signal Transduction', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 6, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.18632/oncotarget.13769', 'pdf_url': 'http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=13769&path%5B%5D=43776', 'source': {'id': 'https://openalex.org/S126644158', 'display_name': 'Oncotarget', 'issn_l': '1949-2553', 'issn': ['1949-2553'], 'is_oa': True, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310316297', 'host_organization_name': 'Impact Journals LLC', 'host_organization_lineage': ['https://openalex.org/P4310316297'], 'host_organization_lineage_names': ['Impact Journals LLC'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': True, 'landing_page_url': 'https://europepmc.org/articles/pmc5356889', 'pdf_url': 'https://europepmc.org/articles/pmc5356889?pdf=render', 'source': {'id': 'https://openalex.org/S4306400806', 'display_name': 'Europe PMC (PubMed Central)', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1303153112', 'host_organization_name': 'European Bioinformatics Institute', 'host_organization_lineage': ['https://openalex.org/I1303153112'], 'host_organization_lineage_names': ['European Bioinformatics Institute'], 'type': 'repository'}, 'license': 'cc-by', 'license_id': 'https://openalex.org/licenses/cc-by', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': True, 'landing_page_url': 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356889', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764455111', 'display_name': 'PubMed Central', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': True, 'landing_page_url': 'https://hdl.handle.net/11573/924958', 'pdf_url': 'https://iris.uniroma1.it/bitstream/11573/924958/2/Morelli_Axitinib-induces_2017.pdf', 'source': {'id': 'https://openalex.org/S4377196107', 'display_name': 'IRIS Research product catalog (Sapienza University of Rome)', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': None, 'host_organization_name': None, 'host_organization_lineage': [], 'host_organization_lineage_names': [], 'type': 'repository'}, 'license': 'other-oa', 'license_id': 'https://openalex.org/licenses/other-oa', 'version': 'submittedVersion', 'is_accepted': False, 'is_published': False}, {'is_oa': True, 'landing_page_url': 'https://hdl.handle.net/11581/395387', 'pdf_url': 'https://pubblicazioni.unicam.it/bitstream/11581/395387.19/1/2017%20axitinib.pdf', 'source': {'id': 'https://openalex.org/S4306400819', 'display_name': 'Unicam Scientific Publications (University of Camerino)', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I112859197', 'host_organization_name': 'Università di Camerino', 'host_organization_lineage': ['https://openalex.org/I112859197'], 'host_organization_lineage_names': ['Università di Camerino'], 'type': 'repository'}, 'license': 'other-oa', 'license_id': 'https://openalex.org/licenses/other-oa', 'version': 'submittedVersion', 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/27926485', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.18632/oncotarget.13769', 'pdf_url': 'http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=13769&path%5B%5D=43776', 'source': {'id': 'https://openalex.org/S126644158', 'display_name': 'Oncotarget', 'issn_l': '1949-2553', 'issn': ['1949-2553'], 'is_oa': True, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310316297', 'host_organization_name': 'Impact Journals LLC', 'host_organization_lineage': ['https://openalex.org/P4310316297'], 'host_organization_lineage_names': ['Impact Journals LLC'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [{'score': 0.55, 'id': 'https://metadata.un.org/sdg/1', 'display_name': 'No poverty'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 49, 'referenced_works': ['https://openalex.org/W1486428308', 'https://openalex.org/W1930421942', 'https://openalex.org/W1939173035', 'https://openalex.org/W1941036222', 'https://openalex.org/W1968291992', 'https://openalex.org/W1974796270', 'https://openalex.org/W1980878904', 'https://openalex.org/W1983052307', 'https://openalex.org/W1983993814', 'https://openalex.org/W1985775217', 'https://openalex.org/W1988692970', 'https://openalex.org/W1995786747', 'https://openalex.org/W1997367417', 'https://openalex.org/W2000835160', 'https://openalex.org/W2010140285', 'https://openalex.org/W2013237763', 'https://openalex.org/W2013287222', 'https://openalex.org/W2021242983', 'https://openalex.org/W2021329972', 'https://openalex.org/W2027974713', 'https://openalex.org/W2039374629', 'https://openalex.org/W2047948621', 'https://openalex.org/W2052032313', 'https://openalex.org/W2069823876', 'https://openalex.org/W2080125477', 'https://openalex.org/W2095247199', 'https://openalex.org/W2101950071', 'https://openalex.org/W2103234174', 'https://openalex.org/W2103562758', 'https://openalex.org/W2105571100', 'https://openalex.org/W2108300681', 'https://openalex.org/W2110385671', 'https://openalex.org/W2116437342', 'https://openalex.org/W2121237369', 'https://openalex.org/W2136380412', 'https://openalex.org/W2144149966', 'https://openalex.org/W2148542297', 'https://openalex.org/W2148607448', 'https://openalex.org/W2148771747', 'https://openalex.org/W2153466677', 'https://openalex.org/W2156320654', 'https://openalex.org/W2158681922', 'https://openalex.org/W2163458899', 'https://openalex.org/W2164660906', 'https://openalex.org/W2165871546', 'https://openalex.org/W2176757944', 'https://openalex.org/W2280439538', 'https://openalex.org/W2289505114', 'https://openalex.org/W2433976232'], 'related_works': ['https://openalex.org/W4300495055', 'https://openalex.org/W4281831295', 'https://openalex.org/W3146265467', 'https://openalex.org/W3032840474', 'https://openalex.org/W3032571198', 'https://openalex.org/W3029266790', 'https://openalex.org/W3028919400', 'https://openalex.org/W2321752808', 'https://openalex.org/W2053506257', 'https://openalex.org/W1973074169'], 'abstract_inverted_index': {'//': [0], 'Maria': [1], 'Beatrice': [2], 'Morelli': [3], '1,': [4, 17], '2': [5, 18, 46], ',': [6, 10, 14, 19, 23, 28, 33], 'Consuelo': [7], 'Amantini': [8], '3': [9, 55], 'Massimo': [11], 'Nabissi': [12], '1': [13, 36, 37], 'Claudio': [15], 'Cardinali': [16], 'Matteo': [20], 'Santoni': [21, 30, 35], '4': [22, 67], 'Giovanni': [24], 'Bernardini': [25], '2,': [26, 31], '5': [27, 32, 78], 'Angela': [29], 'Giorgio': [34, 86], 'School': [38, 56], 'of': [39, 42, 48, 57, 63, 69, 74, 139, 188, 229, 235, 243, 256, 265, 271, 279, 302, 315, 343], 'Pharmacy,': [40], 'University': [41, 62, 73], 'Camerino,': [43, 44, 64, 65], 'Italy': [45, 54, 66, 77, 83], 'Department': [47, 68], 'Molecular': [49], 'Medicine,': [50, 61], 'Sapienza': [51], 'University,': [52], 'Rome,': [53], 'Biosciences': [58], 'and': [59, 157, 167, 173, 190, 196, 281, 284, 318, 325], 'Veterinary': [60], 'Medical': [70], 'Oncology,': [71], 'Polytechnic': [72], 'Marche,': [75], 'Ancona,': [76], 'I.N.M.': [79], 'Neuromed,': [80], 'Pozzilli,': [81], 'Isernia,': [82], 'Correspondence': [84], 'to:': [85], 'Santoni,': [87], 'email:': [88], '[email protected]': [89], 'Keywords:': [90], 'axitinib,': [91], 'glioblastoma,': [92], 'bortezomib,': [93], 'p21,': [94], 'senescence': [95], 'Received:': [96], 'August': [97], '02,': [98], '2016': [99, 103, 107], 'Accepted:': [100], 'November': [101], '18,': [102], 'Published:': [104], 'December': [105], '01,': [106], 'ABSTRACT': [108], 'Glioblastoma': [109], 'is': [110], 'associated': [111], 'with': [112, 186, 237, 240, 267, 308, 347], 'a': [113, 212], 'poor': [114], 'overall': [115], 'survival': [116], 'despite': [117], 'new': [118, 338], 'treatment': [119, 138], 'advances.': [120], 'Antiangiogenic': [121], 'strategies': [122], 'targeting': [123], 'VEGF': [124], 'based': [125], 'on': [126, 276], 'tyrosine': [127], 'kinase': [128, 159], 'inhibitors': [129], '(TKIs)': [130], 'are': [131, 201], 'currently': [132], 'undergoing': [133], 'extensive': [134], 'research': [135], 'for': [136, 340], 'the': [137, 145, 241, 254, 262, 272, 277, 341, 351], 'glioma.': [140], 'Herein': [141], 'we': [142, 179, 260], 'demonstrated': [143], 'that': [144, 181], 'TKI': [146], 'axitinib': [147, 218, 236, 266, 344], 'induces': [148], 'DNA': [149], 'damage': [150], 'response': [151, 216], '(DDR)': [152], 'characterized': [153], 'by': [154, 203, 222], 'γ-H2AX': [155, 324], 'phosphorylation': [156], 'Chk1': [158], 'activation': [160], 'leading': [161], 'to': [162, 217, 290, 349], 'G2/M': [163], 'cell': [164, 176, 192, 198, 209, 223, 230, 287, 300, 305, 310, 319, 332], 'cycle': [165, 224, 320], 'arrest': [166, 225], 'mitotic': [168], 'catastrophe': [169], 'in': [170, 194, 215, 249, 298, 330, 345, 354], 'U87,': [171], 'T98': [172, 197, 282], 'U251': [174, 208, 286], 'glioma': [175, 304, 331], 'lines.': [177, 288, 333], 'Moreover,': [178], 'found': [180], 'p21(Waf1/Cip1)': [182, 326], 'increased': [183], 'levels': [184], 'correlates': [185], 'induction': [187], 'ROS': [189], 'senescence-associated': [191], 'death': [193, 311], 'U87': [195, 280], 'lines,': [199, 306], 'which': [200], 'reverted': [202], 'N-acetyl': [204], 'cysteine': [205], 'pretreatment.': [206], 'Conversely,': [207], 'line': [210], 'showed': [211], 'resistant': [213], 'phenotype': [214], 'treatment,': [219], 'as': [220], 'evidenced': [221], 'but': [226], 'no': [227, 268], 'sign': [228], 'death.': [231], 'The': [232, 313], 'combinatorial': [233], 'use': [234, 342], 'other': [238], 'therapies,': [239], 'aim': [242], 'inhibiting': [244, 299], 'multiple': [245], 'signaling': [246], 'pathways': [247], 'involved': [248], 'tumor': [250], 'growth,': [251], 'can': [252], 'increase': [253], 'efficiency': [255], 'this': [257], 'TKI.': [258], 'Thus,': [259], 'addressed': [261], 'combined': [263, 293], 'effects': [264], 'toxic': [269], 'doses': [270], 'proteasome': [273], 'inhibitor': [274], 'bortezomib': [275], 'growth': [278], 'axitinib-sensitive': [283], 'axitinib-resistant': [285], 'Compared': [289], 'single': [291], 'treatments,': [292], 'exposure': [294], 'was': [295, 327], 'more': [296], 'effective': [297], 'viability': [301], 'all': [303], 'although': [307], 'different': [309], 'modalities.': [312], 'regulation': [314], 'key': [316], 'DDR': [317], 'proteins,': [321], 'including': [322], 'Chk1,': [323], 'also': [328], 'studied': [329], 'Collectively,': [334], 'these': [335], 'findings': [336], 'provide': [337], 'perspectives': [339], 'combination': [346], 'Bortezomib': [348], 'overcome': [350], 'therapy': [352], 'resistance': [353], 'gliomas.': [355]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2558754297', 'counts_by_year': [{'year': 2024, 'cited_by_count': 6}, {'year': 2023, 'cited_by_count': 3}, {'year': 2022, 'cited_by_count': 4}, {'year': 2021, 'cited_by_count': 8}, {'year': 2020, 'cited_by_count': 5}, {'year': 2019, 'cited_by_count': 4}, {'year': 2018, 'cited_by_count': 3}, {'year': 2017, 'cited_by_count': 4}], 'updated_date': '2024-12-18T16:30:08.803927', 'created_date': '2016-12-08'}